Buy Cebaracetam Cas 113957-09-8

Buy Cebaracetam Cas 113957-09-8

Cebaracetam (INNTooltip International Nonproprietary Name; developmental code names CGS-25248; ZY-15119) is an experimental drug of the racetam group described as a nootropic which was never marketed.^[1][2][3]

It is a chlorinated acetylpiperazine–substituted analogue of phenylpiracetam and is also a derivative of RGPU-95 (4-chlorophenylpiracetam).^[4] It is the analogue of RGPU-95 in which the terminal amide group has been replaced with a piperazin-2-one moiety.^[4] The mechanism of action of cebaracetam is undefined or unknown.^[1]

The drug was under development by Novartis for the treatment of cognition disorders by the 1990s but development was discontinued in 1995.^[1] It reached phase 2 clinical trials prior to its discontinuation.^[1]